Loading...
Printed on 4/19/2026
For informational purposes only. This is not medical advice.
HOMA-Beta (HOMA-%B) estimates pancreatic beta-cell function from fasting insulin and fasting glucose. It is often interpreted together with HOMA-IR and other glycemic markers to understand insulin secretion relative to insulin resistance.
Formula: HOMA-Beta = (360 x Fasting Insulin [uIU/mL]) / (Fasting Glucose [mg/dL] - 63)
HOMA-Beta estimates beta-cell function; lower values may suggest reduced insulin secretory reserve, while higher values can reflect compensatory hyperinsulinemia.
Use HOMA-Beta when evaluating fasting insulin secretion patterns in prediabetes and type 2 diabetes risk assessment.
HOMA-Beta is a fasting-model estimate and is affected by assay variability and population differences. It should not be used alone for diagnosis or treatment decisions.
For related assessments, see HOMA-IR, QUICKI and HbA1c Converter.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
Estimate insulin resistance using fasting glucose and fasting insulin with the HOMA-IR equation.
EndocrinologyEstimate insulin sensitivity using fasting glucose and fasting insulin with the QUICKI formula.
EndocrinologyConvert HbA1c to estimated average glucose (eAG): 6%=126 mg/dL, 7%=154, 8%=183, 9%=212. ADA 2026 target <7% for most adults with diabetes. Shows both mg/dL and mmol/L.